519 related articles for article (PubMed ID: 34604310)
1. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
[TBL] [Abstract][Full Text] [Related]
2. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
3. Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy.
McMahon A; Chen W; Li F
J Control Release; 2020 Mar; 319():352-359. PubMed ID: 31911155
[TBL] [Abstract][Full Text] [Related]
4. Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems.
Kang X; Jadhav S; Annaji M; Huang CH; Amin R; Shen J; Ashby CR; Tiwari AK; Babu RJ; Chen P
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376016
[TBL] [Abstract][Full Text] [Related]
5. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
Chen W; Yang W; Chen P; Huang Y; Li F
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
[TBL] [Abstract][Full Text] [Related]
6. An Updated Review of Disulfiram: Molecular Targets and Strategies for Cancer Treatment.
Yang Q; Yao Y; Li K; Jiao L; Zhu J; Ni C; Li M; Dou QP; Yang H
Curr Pharm Des; 2019; 25(30):3248-3256. PubMed ID: 31419930
[TBL] [Abstract][Full Text] [Related]
7. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
[TBL] [Abstract][Full Text] [Related]
8. Cancer Pro-oxidant Therapy Through Copper Redox Cycling:
Rieber M
Curr Pharm Des; 2020; 26(35):4461-4466. PubMed ID: 32600223
[TBL] [Abstract][Full Text] [Related]
9. The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway.
Guo W; Zhang X; Lin L; Wang H; He E; Wang G; Zhao Q
J Biochem; 2021 Oct; 170(2):275-287. PubMed ID: 33792698
[TBL] [Abstract][Full Text] [Related]
10. Smart Tumor Microenvironment-Responsive Nano-Prodrug for Disulfiram Toxification In Situ and the Exploration of Lethal Mechanisms in Cells.
Zhang Y; Qi G; Qu X; Wang B; Ma K; Jin Y
Langmuir; 2022 Jan; 38(1):584-592. PubMed ID: 34971310
[TBL] [Abstract][Full Text] [Related]
11. Disulfiram: A novel repurposed drug for cancer therapy.
Zeng M; Wu B; Wei W; Jiang Z; Li P; Quan Y; Hu X
Chin Med J (Engl); 2024 Jan; ():. PubMed ID: 38275022
[TBL] [Abstract][Full Text] [Related]
12. The combination of disulfiram and copper for cancer treatment.
Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W
Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854
[TBL] [Abstract][Full Text] [Related]
13. Sphingomyelin-based PEGylation Cu (DDC)
Liu H; Kong Y; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
Int J Pharm; 2022 Jun; 621():121788. PubMed ID: 35504431
[TBL] [Abstract][Full Text] [Related]
14. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
[TBL] [Abstract][Full Text] [Related]
15. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.
Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer.
Chang Y; Jiang J; Chen W; Yang W; Chen L; Chen P; Shen J; Qian S; Zhou T; Wu L; Hong L; Huang Y; Li F
Appl Mater Today; 2020 Mar; 18():. PubMed ID: 34746366
[TBL] [Abstract][Full Text] [Related]
17. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the accumulation of disulfiram and its copper complex in A549 cells using mass spectrometry.
Lu X; Lin B; Xu N; Huang H; Wang Y; Lin JM
Talanta; 2020 May; 211():120732. PubMed ID: 32070566
[TBL] [Abstract][Full Text] [Related]
19. Disulfiram/copper-disulfiram Damages Multiple Protein Degradation and Turnover Pathways and Cytotoxicity is Enhanced by Metformin in Oesophageal Squamous Cell Carcinoma Cell Lines.
Jivan R; Damelin LH; Birkhead M; Rousseau AL; Veale RB; Mavri-Damelin D
J Cell Biochem; 2015 Oct; 116(10):2334-43. PubMed ID: 25846272
[TBL] [Abstract][Full Text] [Related]
20. Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens.
Lu Y; Pan Q; Gao W; Pu Y; Luo K; He B; Gu Z
Biomaterials; 2022 Feb; 281():121335. PubMed ID: 34979419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
